Phase 4 Prostate cancer trials recruiting now

All Prostate cancer trials, every phase

Other phases for Prostate cancer

Phase 4 Prostate cancer trials

• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
  NCT06706921 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
  NCT05348876 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 25 locations
• Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
  NCT05629494 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: Male · 3 locations
• Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)
  NCT07001709 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
  NCT04373564 · Phase: Phase 4 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 102 locations
• Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
  NCT07252726 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
  NCT05919329 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
  NCT07569926 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 6 locations
• Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.
  NCT06784986 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: Male · 2 locations
• Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
  NCT06908694 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
• Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
  NCT05803941 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: Male · 54 locations
• PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
  NCT06875258 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: Male · 3 locations
• Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
  NCT06099093 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 2 locations
• Preop Laxatives in Robotic Urologic Surgery
  NCT05805436 · Phase: Phase 4 · Ages: 30 Years to 100 Years · Sex: All (male and female) · 1 location
• Prostate Medication, Metabolism and Gut Microbiota
  NCT06001619 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 2 locations
• Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
  NCT06733350 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.